Overview

Prehospital Kcentra for Hemorrhagic Shock

Status:
Active, not recruiting

Trial end date:
2022-09-01

Target enrollment:

Participant gender:

Summary

This is a pilot trial being performed to evaluate the feasibility, to include the ability of EMS to identify patients in shock and the ability to package, store, and administer Kcentra in the field.

Phase:

Phase 2

Details

Lead Sponsor:

Oregon Health and Science University

Treatments:

Protein C
Protein S
Thrombin